Literature DB >> 29733939

Ethnic differences and comorbidities of 909 prurigo nodularis patients.

Emily Boozalis1, Olive Tang2, Shivani Patel1, Yevgeniy R Semenov3, Manuel P Pereira4, Sonja Stander4, Sewon Kang1, Shawn G Kwatra5.   

Abstract

BACKGROUND: Prurigo nodularis (PN) is a poorly understood, understudied pruritic dermatosis that reduces quality of life.
OBJECTIVE: To characterize the demographics and comorbidities associated with PN.
METHODS: Cross-sectional study of patients 18 years and older who were seen at the Johns Hopkins Health System between December 6, 2012, and December 6, 2017.
RESULTS: Over the past 5 years, 909 patients with PN were seen at Johns Hopkins Health System. African American patients were 3.4 times more likely to have PN than white patients were (odds ratio [OR], 3.4; 95% confidence interval [CI], 2.9-3.9; P < .001). A comparison of the study patients and race-matched controls revealed that PN was significantly associated with a variety of systemic, cardiovascular, and psychiatric comorbidities, including chronic kidney disease, chronic hepatitis C, chronic obstructive pulmonary disease, congestive heart failure, depression, and atopic dermatitis. Black patients with PN were 10.5 times more likely (OR, 10.5; 95% CI, 7.9-13.9; P < .001) to have HIV than were race-matched controls with atopic dermatitis, and 8 times more likely (OR, 8.0; 95% CI, 5.7-11.1; P < .001) to have HIV than were African American patients with psoriasis. LIMITATIONS: Our data describe patients seen by 1 hospital system. Our data identify associated conditions and comorbidities but are unable to support a causal relationship.
CONCLUSION: PN disproportionately affects African Americans and is associated with several systemic conditions, including HIV, chronic kidney disease, and diabetes.
Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; PN; atopic dermatitis; chronic kidney disease; itch; prurigo nodularis; pruritus; psoriasis

Mesh:

Year:  2018        PMID: 29733939      PMCID: PMC6518410          DOI: 10.1016/j.jaad.2018.04.047

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  24 in total

Review 1.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

2.  Psychiatric Comorbidity in Prurigo Nodularis and the Impact of Socioeconomic Status.

Authors:  Jane Han; Angelina Palomino; Blanca Estupinan; Amy Wozniak; James Swan
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 3.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

4.  Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center.

Authors:  Alexandra M Bender; Olive Tang; Raveena Khanna; Sonja Ständer; Sewon Kang; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2019-09-06       Impact factor: 11.527

Review 5.  Itch: Epidemiology, clinical presentation, and diagnostic workup.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2021-08-21       Impact factor: 11.527

6.  Comorbidities of Prurigo Nodularis in Finland Between 1996 and 2019.

Authors:  Kristian Wikström; Henri Verkko; Suvi-Päivikki Sinikumpu; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

7.  A Nationwide Study of Prurigo Nodularis: Disease Burden and Healthcare Utilization in the United States.

Authors:  Shannon Wongvibulsin; Nishadh Sutaria; Kyle A Williams; Amy H Huang; Justin Choi; Youkyung Sophie Roh; Michael Hong; Davis Kelley; Vartan Pahalyants; William Murphy; Martin Prince Alphonse; Pegah Bakhshi; Anant Walia; Yevgeniy R Semenov; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-04-03       Impact factor: 7.590

8.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

9.  Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities.

Authors:  Giuseppe Lanza; Filomena Irene Ilaria Cosentino; Raffaele Ferri; Bartolo Lanuzza; Maddalena Siragusa; Mariangela Tripodi; Carmelo Schepis
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

10.  Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.

Authors:  Sonja Ständer; Miriam Ketz; Nils Kossack; Divine Akumo; Marc Pignot; Sylvie Gabriel; Rajeev Chavda
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.